298 related articles for article (PubMed ID: 20227043)
21. Neuregulin-1 enhances survival of human astrocytic glioma cells.
Ritch PS; Carroll SL; Sontheimer H
Glia; 2005 Aug; 51(3):217-28. PubMed ID: 15812817
[TBL] [Abstract][Full Text] [Related]
22. A naturally occurring secreted human ErbB3 receptor isoform inhibits heregulin-stimulated activation of ErbB2, ErbB3, and ErbB4.
Lee H; Akita RW; Sliwkowski MX; Maihle NJ
Cancer Res; 2001 Jun; 61(11):4467-73. PubMed ID: 11389077
[TBL] [Abstract][Full Text] [Related]
23. Expression of neuregulin and ErbB3 and ErbB4 after a traumatic lesion in the ventral funiculus of the spinal cord and in the intact primary olfactory system.
Lindholm T; Cullheim S; Deckner M; Carlstedt T; Risling M
Exp Brain Res; 2002 Jan; 142(1):81-90. PubMed ID: 11797086
[TBL] [Abstract][Full Text] [Related]
24. Heregulin selectively upregulates vascular endothelial growth factor secretion in cancer cells and stimulates angiogenesis.
Yen L; You XL; Al Moustafa AE; Batist G; Hynes NE; Mader S; Meloche S; Alaoui-Jamali MA
Oncogene; 2000 Jul; 19(31):3460-9. PubMed ID: 10918604
[TBL] [Abstract][Full Text] [Related]
25. A novel neuregulin - jagged1 paracrine loop in breast cancer transendothelial migration.
Cabrera RM; Mao SPH; Surve CR; Condeelis JS; Segall JE
Breast Cancer Res; 2018 Apr; 20(1):24. PubMed ID: 29636067
[TBL] [Abstract][Full Text] [Related]
26. Constitutive activation of the neuregulin-1/ErbB receptor signaling pathway is essential for the proliferation of a neoplastic Schwann cell line.
Frohnert PW; Stonecypher MS; Carroll SL
Glia; 2003 Aug; 43(2):104-18. PubMed ID: 12838503
[TBL] [Abstract][Full Text] [Related]
27. Bone marrow-derived mesenchymal stem cells promote colorectal cancer progression through paracrine neuregulin 1/HER3 signalling.
De Boeck A; Pauwels P; Hensen K; Rummens JL; Westbroek W; Hendrix A; Maynard D; Denys H; Lambein K; Braems G; Gespach C; Bracke M; De Wever O
Gut; 2013 Apr; 62(4):550-60. PubMed ID: 22535374
[TBL] [Abstract][Full Text] [Related]
28. c-Src modulates ErbB2 and ErbB3 heterocomplex formation and function.
Ishizawar RC; Miyake T; Parsons SJ
Oncogene; 2007 May; 26(24):3503-10. PubMed ID: 17173075
[TBL] [Abstract][Full Text] [Related]
29. In vivo knockdown of ErbB3 in mice inhibits Schwann cell precursor migration.
Torii T; Miyamoto Y; Takada S; Tsumura H; Arai M; Nakamura K; Ohbuchi K; Yamamoto M; Tanoue A; Yamauchi J
Biochem Biophys Res Commun; 2014 Sep; 452(3):782-8. PubMed ID: 25204498
[TBL] [Abstract][Full Text] [Related]
30. HER3 is required for the maintenance of neuregulin-dependent and -independent attributes of malignant progression in prostate cancer cells.
Soler M; Mancini F; Meca-Cortés O; Sánchez-Cid L; Rubio N; López-Fernández S; Lozano JJ; Blanco J; Fernández PL; Thomson TM
Int J Cancer; 2009 Dec; 125(11):2565-75. PubMed ID: 19530240
[TBL] [Abstract][Full Text] [Related]
31. Neuregulin 1-erbB signaling and the molecular/cellular basis of schizophrenia.
Corfas G; Roy K; Buxbaum JD
Nat Neurosci; 2004 Jun; 7(6):575-80. PubMed ID: 15162166
[TBL] [Abstract][Full Text] [Related]
32. Neuregulin-1-mediated autocrine signaling underlies sensitivity to HER2 kinase inhibitors in a subset of human cancers.
Wilson TR; Lee DY; Berry L; Shames DS; Settleman J
Cancer Cell; 2011 Aug; 20(2):158-72. PubMed ID: 21840482
[TBL] [Abstract][Full Text] [Related]
33. Exploring the Binding Mechanism of NRG1-ERBB3 Complex and Discovery of Potent Natural Products to Reduce Diabetes-Assisted Breast Cancer Progression.
Marafie SK; Alshawaf E; Abu-Farha M; Thanaraj TA; Wei DQ; Al-Mulla F; Khan A; Abubaker J; Mohammad A
Interdiscip Sci; 2023 Sep; 15(3):452-464. PubMed ID: 37389721
[TBL] [Abstract][Full Text] [Related]
34. The outcome of heregulin-induced activation of ovarian cancer cells depends on the relative levels of HER-2 and HER-3 expression.
Xu F; Yu Y; Le XF; Boyer C; Mills GB; Bast RC
Clin Cancer Res; 1999 Nov; 5(11):3653-60. PubMed ID: 10589783
[TBL] [Abstract][Full Text] [Related]
35. Growth regulation of human breast and ovarian tumor cells by heregulin: Evidence for the requirement of ErbB2 as a critical component in mediating heregulin responsiveness.
Lewis GD; Lofgren JA; McMurtrey AE; Nuijens A; Fendly BM; Bauer KD; Sliwkowski MX
Cancer Res; 1996 Mar; 56(6):1457-65. PubMed ID: 8640840
[TBL] [Abstract][Full Text] [Related]
36. Essential role for Rac in heregulin beta1 mitogenic signaling: a mechanism that involves epidermal growth factor receptor and is independent of ErbB4.
Yang C; Liu Y; Lemmon MA; Kazanietz MG
Mol Cell Biol; 2006 Feb; 26(3):831-42. PubMed ID: 16428439
[TBL] [Abstract][Full Text] [Related]
37. Neuregulin-1 only induces trans-phosphorylation between ErbB receptor heterodimer partners.
Li Z; Mei Y; Liu X; Zhou M
Cell Signal; 2007 Mar; 19(3):466-71. PubMed ID: 16978839
[TBL] [Abstract][Full Text] [Related]
38. Role of erbB3 receptors in cancer therapeutic resistance.
Lee Y; Ma J; Lyu H; Huang J; Kim A; Liu B
Acta Biochim Biophys Sin (Shanghai); 2014 Mar; 46(3):190-8. PubMed ID: 24449784
[TBL] [Abstract][Full Text] [Related]
39. Downregulation of erbB3 abrogates erbB2-mediated tamoxifen resistance in breast cancer cells.
Liu B; Ordonez-Ercan D; Fan Z; Edgerton SM; Yang X; Thor AD
Int J Cancer; 2007 May; 120(9):1874-82. PubMed ID: 17266042
[TBL] [Abstract][Full Text] [Related]
40. Growth stimulation of non-small cell lung cancer cell lines by antibody against epidermal growth factor receptor promoting formation of ErbB2/ErbB3 heterodimers.
Maegawa M; Takeuchi K; Funakoshi E; Kawasaki K; Nishio K; Shimizu N; Ito F
Mol Cancer Res; 2007 Apr; 5(4):393-401. PubMed ID: 17426253
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
